Literature DB >> 25696582

Sudden cardiac death: time to make a difference: Pro ICD.

M J Schalij, L van Erven.   

Abstract

Entities:  

Year:  2006        PMID： 25696582      PMCID： PMC2557339     

Source DB:  PubMed          Journal:  Neth Heart J        ISSN： 1568-5888            Impact factor:   2.380


× No keyword cloud information.
  19 in total

1.  Benefit of combined resynchronization and defibrillator therapy in heart failure patients with and without ventricular arrhythmias.

Authors:  Claudia Ypenburg; Lieselot van Erven; Gabe B Bleeker; Jeroen J Bax; Marianne Bootsma; Maurits C Wijffels; Ernst E van der Wall; Martin J Schalij
Journal:  J Am Coll Cardiol       Date:  2006-07-12       Impact factor: 24.094

2.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

3.  Design and results of the antiarrhythmics vs implantable defibrillators (AVID) registry. The AVID Investigators.

Authors:  J L Anderson; A P Hallstrom; A E Epstein; S L Pinski; Y Rosenberg; M O Nora; D Chilson; D S Cannom; R Moore
Journal:  Circulation       Date:  1999-04-06       Impact factor: 29.690

4.  Quantitative overview of randomized trials of amiodarone to prevent sudden cardiac death.

Authors:  I Sim; K M McDonald; P W Lavori; C M Norbutas; M A Hlatky
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

5.  Standardized screening and treatment of patients with life-threatening arrhythmias: the Leiden out-of-hospital cardiac arrest evaluation study.

Authors:  Alida E Borger van der Burg; Jeroen J Bax; Eric Boersma; Lieselot van Erven; Marianne Bootsma; Ernst E van der Wall; Martin J Schalij
Journal:  Heart Rhythm       Date:  2004-05       Impact factor: 6.343

6.  Randomised trial of outcome after myocardial infarction in patients with frequent or repetitive ventricular premature depolarisations: CAMIAT. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial Investigators.

Authors:  J A Cairns; S J Connolly; R Roberts; M Gent
Journal:  Lancet       Date:  1997-03-08       Impact factor: 79.321

7.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R Kleiger; J P Miller; L M Rolnitzky
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

8.  Nonsustained ventricular tachycardia in ambulatory patients: characteristics and association with sudden cardiac death.

Authors:  W P Follansbee; E L Michelson; J Morganroth
Journal:  Ann Intern Med       Date:  1980-06       Impact factor: 25.391

9.  Impact of viability, ischemia, scar tissue, and revascularization on outcome after aborted sudden death.

Authors:  Alida E Borger van der Burg; Jeroen J Bax; Eric Boersma; Ernest K J Pauwels; Ernst E van der Wall; Martin J Schalij
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

10.  Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.

Authors:  S N Singh; R D Fletcher; S G Fisher; B N Singh; H D Lewis; P C Deedwania; B M Massie; C Colling; D Lazzeri
Journal:  N Engl J Med       Date:  1995-07-13       Impact factor: 91.245
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.